Interestingly, in this CRS mouse model, serum cytokine levels of markers such as tumor necrosis factor alpha (TNF-α) and interferon-gamma (IFN-γ) were reduced in the presence of ibrutinib [94]. This evidence concerns the gene TNF and congenital rubella syndrome.